Baird Financial Group, Inc. Pacific Biosciences Of California, Inc. Transaction History

Baird Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$4.02 - $10.43 $77,200 - $200,297	-19,204 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.43 - $20.9 $65,981 - $163,584	7,827 Added 68.8%	19,204 $175,000
Q4 2021 Feb 09, 2022	SELL	$19.26 - $30.08 $2,600 - $4,060	-135 Reduced 1.17%	11,377 $233,000
Q3 2021 Nov 12, 2021	BUY	$24.86 - $35.02 $286,188 - $403,150	11,512 New	11,512 $294,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.